T1	Entity 0 9	Vitamin D
T2	SNP 18 34	genetic variants
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T3	Entity 54 72	vitamin D exposure
T4	Cancer 78 91	breast cancer
T5	Association 92 96	risk
E1	Association:T5 bc:T4 snp_int:T2 snp_int2:T51
T6	Entity 103 129	Caucasian women in Ontario
R3	Population_assignment Arg1:T2 Arg2:T6	
T7	Spec 238 250	investigated
T8	Entity 264 268;281 299	gene vitamin D pathways
T9	SNP 269 277	variants
R4	SNP_coupled_gene Arg1:T9 Arg2:T8	
T10	Association 304 314	associated
E2	Association:T10 snp_int:T9 bc:T11
R5	Speculation_marker Arg1:E2 Arg2:T7	
T11	Cancer 320 333	breast cancer
T12	Therapeutic_response 343 349	modify
E3	Therapeutic_response:T12 Theme2:T11 Agent:T50
T13	Entity 393 411	vitamin D exposure
T14	Entity 433 452	aged 25 to 74 years
R6	Speculation_marker Arg1:E3 Arg2:T7	
R7	Risk_Factor Arg1:T9 Arg2:T14	
T15	Entity 838 861	vitamin D related genes
T16	Entity 873 898	vitamin D binding protein
T17	Entity 900 902	GC
R9	Equiv Arg1:T17 Arg2:T16	
T18	Entity 905 923	vitamin D receptor
T19	Entity 925 928	VDR
R10	Equiv Arg1:T19 Arg2:T18	
T20	Entity 935 960	cytochrome P450 type 24A1
T21	Entity 962 969	CYP24A1
R11	Equiv Arg1:T21 Arg2:T20	
R12	Member Arg1:T15 Arg2:T16	
R13	Member Arg1:T15 Arg2:T18	
R14	Member Arg1:T15 Arg2:T20	
T22	Spec 764 772	evaluate
T23	Association 773 785	associations
E4	Association:T23 snp_int:T24 bc:T11
R15	Speculation_marker Arg1:E4 Arg2:T22	
T24	SNP 794 828	19 single nucleotide polymorphisms
T25	SNP 797 828	single nucleotide polymorphisms
T26	SNP 830 833	SNP
R16	Equiv Arg1:T26 Arg2:T25	
R17	Equiv Arg1:T24 Arg2:T9	
R18	SNP_coupled_gene Arg1:T24 Arg2:T15	
R19	Equiv Arg1:T8 Arg2:T15	
T27	SNP 1044 1053	Some SNPs
T28	Level 1071 1084	significantly
T29	Association 1085 1095	associated
E5	Association:T29 bc:T30 snp_int:T27
A1	Level E5 High
T30	Cancer 1101 1114	breast cancer
R20	Level_marker Arg1:E5 Arg2:T28	
T31	Cancer 1134 1147	breast cancer
T32	Entity 1177 1179	GC
T33	SNP 1180 1186	rs7041
T34	Entity 1187 1189	TT
R22	Genotype Arg1:T33 Arg2:T34	
R23	SNP_coupled_gene Arg1:T33 Arg2:T32	
T35	Association 1157 1167	associated
E6	Association:T35 snp_int:T33 bc:T31
T36	SNP 1290 1299	rs2228570
T37	Entity 1280 1283	VDR
T38	SNP 1284 1288	Fok1
R24	Equiv Arg1:T36 Arg2:T38	
R25	SNP_coupled_gene Arg1:T38 Arg2:T37	
T39	Entity 1301 1303	ff
R26	Genotype Arg1:T36 Arg2:T39	
E7	Association:T35 bc:T31 snp_int:T36
T40	Effect_Type 1261 1270	inversely
R27	Effect_type_marker Arg1:E7 Arg2:T40	
A2	Effect_Type E7 Decrease
A3	SNP_Type T36 Missense
R28	Member Arg1:T27 Arg2:T33	
R29	Member Arg1:T27 Arg2:T36	
R21	Level_marker Arg1:E7 Arg2:T28	
R30	Level_marker Arg1:E6 Arg2:T28	
A4	Level E7 High
A5	Level E6 High
R31	Member Arg1:T24 Arg2:T27	
T41	SNP 1473 1480;1499 1515	certain genetic variants
R2	Equiv Arg1:T41 Arg2:T27	
T42	Spec 1516 1519	may
T43	Association 1520 1529	influence
E8	Association:T43 bc:T44 snp_int:T41
T44	Cancer 1530 1543	breast-cancer
R32	Speculation_marker Arg1:E8 Arg2:T42	
T45	Entity 1481 1498	vitamin D related
R33	SNP_coupled_gene Arg1:T41 Arg2:T45	
T46	Spec 1562 1578	limited evidence
T47	SNP 1584 1600	genetic variants
T48	Therapeutic_response 1601 1607;1670 1674	modify risk
E9	Therapeutic_response:T48 Agent:T47
T49	Entity 1633 1651	vitamin D exposure
R34	Speculation_marker Arg1:E9 Arg2:T46	
R35	SNP_coupled_gene Arg1:T47 Arg2:T45	
T50	SNP 269 277	variants
R38	SNP_coupled_gene Arg1:T50 Arg2:T8	
R8	Risk_Factor Arg1:T50 Arg2:T13	
R39	Risk_Factor Arg1:T50 Arg2:T14	
T51	SNP 18 34	genetic variants
R37	Risk_Factor Arg1:T51 Arg2:T3	
R40	SNP_coupled_gene Arg1:T51 Arg2:T1	
R41	Population_assignment Arg1:T51 Arg2:T6	
R42	Population_assignment Arg1:T9 Arg2:T6	
R43	Population_assignment Arg1:T50 Arg2:T6	
R36	Member Arg1:T24 Arg2:T47	
T52	Cancer 1656 1669	breast cancer
R44	Risk_Factor Arg1:T47 Arg2:T49	
A6	SNP_Type T38 Missense
